Target (TGT) says it is lowering prices on 3,000 Spring products, including everyday essentials
Newsquawk Staff ·
Target (TGT) says it is lowering prices on 3,000 Spring products, including everyday essentials.
What it means
Target's decision to lower prices on 3,000 spring products suggests a strategic move to attract shoppers, especially in a competitive retail landscape. This could indicate pressure on margins but aims to enhance volume sales, which is vital as consumer spending patterns evolve. Investors should consider how this pricing strategy may impact Target's revenue outlook and overall sector performance.
Sources
- Verisk (VRSK) integrates insurance intelligence with Amazon (AMZN) and Microsoft (MSFT) AI platforms
- Senior US Treasury trade official Eric Ettorre will leave to join Netflix (NFLX), reports Axios
- US Midterms (6 days out): Florida flips to a Republican early-vote lead and Kansas narrows further; Crystal Ball shifts House and Senate races towards Democrats
- T-Mobile (TMUS) CEO to step down from the board
- US PRE-MARKET MOVERS: SKHY, NXPI, ENPH, APH, GOOGL, HOOD, PPG, VRT, GEV, GEHC, BSX, ETSY, WEN, V
Related headlines
- US Broker Moves: ENPH and DYN downgraded at Oppenheimer; FFIV downgraded at Piper Sandler2 hours ago
- Amphenol (APH) Q3 2026 (USD): Adj. EPS 0.80 (exp. 0.73), Sales 10.2bln (exp. 9.49bln)2 hours ago
- GE Vernova (GEV) expects USD 50-100mln of annual cost synergies from Trench by 2030, according to the conference call2 hours ago
- UK Budget, 28th October 2026: An uneventful budget expected, but the reaction risks are skewed negative2 hours ago
- Daily US Conference Calendar - 28th October 2026: JNJ, BA, CAT2 hours ago
- Etsy Inc. (ETSY) Q3 2026 (USD): EPS 1.00 (exp. 0.77), Revenue 692mln (exp. 668mln)3 hours ago
- Etsy (ETSY) CFO Baker is to leave on March 1st 2027, will remain an advisor through July 1st 20273 hours ago
- Garmin Ltd. (GRMN) Q3 2026 (USD): Adj. EPS 2.76 (exp. 2.41), Revenue 1.99bln (exp. 1.99bln)3 hours ago
- Phillips 66 (PSX) Q3 2026 (USD): Adj. EPS 14.08 (exp. 11.73)3 hours ago
- Eli Lilly’s (LLY) retatrutide delivered greater A1C reduction and more than double the weight loss of Novo Nordisk’s (NOVOB DC) Ozempic at its highest approved dose in head-to-head trial3 hours ago
- Aon (AON) Q3 (USD): Adj. EPS 3.36 (exp. 3.30), Revenue 4.1bln (exp. 4.08bln)3 hours ago
- GE Healthcare Technologies Inc. (GEHC) Q3 (USD): Adj. EPS 1.34 (exp. 1.20), Revenue 5.5bln (exp. 5.35bln), Adj. EBIT 913mln (exp. 838.8mln)3 hours ago
- GE Vernova Inc. (GEV) Q3 (USD) Revenue 12.6bln (exp. 11.99bln), Adj. EBITDA 1.9bln (exp. 1.69bln). Current FY Rev. 46-5-47.5bln (exp. 46.33bln)3 hours ago
- GE Vernova (GEV) to acquire Trench Group for USD 9bln3 hours ago
- Otis Worldwide (OTIS) Q3 2026 (USD): Adj. EPS 1.05 (exp. 1.01), Revenue 3.9bln (exp. 3.85bln). Maintains FY26 guidance4 hours ago